Published in Vaccine Weekly, June 26th, 2002
Two studies were conducted using human volunteers to demonstrate the effectiveness of the needle-free injection system, code named the MJ8. The key feature assessed was injection quality, and more than 500 injections were administered and evaluated. The preliminary results confirm that the device administers a high quality subcutaneous injection. The company believes that the new device...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.